C-reactive protein, identified as an acute-phase reactant linked to metabolic syndrome and cardiovascular disease, experiences elevated levels in circulation when interleukin-6 (IL-6) is released by macrophages and T cells [118]. Here, IL6 is linked to cardiovascular disorder.